Onconetix (ONCO) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$6.25.
- Onconetix's EPS (Weighted Average and Diluted) rose 9749.08% to -$6.25 in Q3 2025 from the same period last year, while for Sep 2025 it was $3049.1, marking a year-over-year increase of 22140.24%. This contributed to the annual value of -$21.45 for FY2024, which is 7546.96% up from last year.
- Onconetix's EPS (Weighted Average and Diluted) amounted to -$6.25 in Q3 2025, which was up 9749.08% from -$4.76 recorded in Q2 2025.
- Onconetix's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.18 during Q1 2023, with a 5-year trough of -$2191.6 in Q2 2024.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$10.8 (2024), whereas its average is -$231.65.
- As far as peak fluctuations go, Onconetix's EPS (Weighted Average and Diluted) plummeted by 50774661.07% in 2024, and later soared by 9978.29% in 2025.
- Onconetix's EPS (Weighted Average and Diluted) (Quarter) stood at -$52.25 in 2023, then skyrocketed by 79.33% to -$10.8 in 2024, then soared by 42.12% to -$6.25 in 2025.
- Its last three reported values are -$6.25 in Q3 2025, -$4.76 for Q2 2025, and -$0.53 during Q1 2025.